Physician
Robert M Fliegelman, DO
According to 2025 Medicare claims, Robert Fliegelman, DO (NPI: 1821084120) practices infectious disease in the Bloomington, IN market, with the plurality of this provider's patient population coming from Monroe, IN. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 47403-5004. Fliegelman is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.
Fliegelman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 172 traditional Medicare patients, billed 28,997 HCPCS/CPT codes, and received $508,107 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 105 prescription claims across 34 beneficiaries totaling $118,588 in drug costs, led by Dovato (Dolutegravir Sodium/Lamivudine). 2018 DME data shows 23 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,218,993 to $508,107. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $155,970 and ending at $118,588. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.